Platelet counts in depressed patients treated with amitriptyline or paroxetine

European Psychiatry

Volumn 18, Issue 2, 2003, Pages 89-91

  Lederbogen, F ^a   Horer E ^a   Hellweg, R ^b   Heuser, I ^a,b   Deuschle, M ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Antidepressant; Depression; Platelet count

Indexed keywords

AMITRIPTYLINE; PAROXETINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MECHANISM; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OBSERVATION; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE COUNT; THROMBOCYTOSIS; THROMBOEMBOLISM;

EID: 0038643076     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(03)00006-3     Document Type: Article

References (18)

1. Ariyo AA, Haan M, Tangen CM, Rutledge JC, Cushman M, Dobs A, et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Circulation 2000;102:1773-9.
2. Berk M, Jacobson BF, Hurly E. Fluoxetine and hemostatic function: a pilot study. J Clin Psychiatry 1995;56:14-6.
3. Canoso R. Effects of neuroleptics on the immune system. In: Kane JM, Lieberman JA, editors. Adverse effects of psychotropic drugs. New York: The Guilford Press; 1992. p. 395-487.
4. Deuschle M, Hamann B, Meichel C, Krumm B, Lederbogen F, Kniest A, et al. Antidepressive treatment with amitriptyline and paroxetine: effects upon saliva cortisol concentrations. J Clin Psychopharmacol (in press).
5. Glassman A, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998;155:4-11.
6. Heuser I. The hypothalamic-pituitary-adrenal system in depression. Pharmacopsychiatry 1998;31:10-3.
7. Hoeksema T, Goekoop JG, Van Kempen GMJ. Effects of fluvoxamine on whole-blood serotonin and platelet number. J Clin Psychopharmacol 1993;13:75-6.
8. Krivy J, Wiener J. Sertraline and platelet counts in idiopathic thrombocytopenia purpura. Lancet 1995;345:132.
9. Lake MB, Birmaher B, Wassick S, Mathos K, Yelovich AK. Bleeding and selective serotonin reuptake inhibitors in childhood and adolescence. J Child Adolesc Psychopharmacol 2000;10:35-8.
10. Lederbogen F, Gilles M, Maras A, Hamann B, Colla M, Heuser I, et al. Increased platelet aggregability in major depression? Psychiatry Res 2001;102:255-61.
11. Maes M, Scharpe S, Bosmans E, Vandewoude M, Suy E, Uyttenbroeck W, et al. Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:501-15.
12. Markovitz JH, Matthews KA, Kiss J, Smitherman TC. Effects of hostility on platelet reactivity to psychological stress in coronary heart disease patients and in healthy controls. Psychosom Med 1996;58:143-9.
13. Musselman DL, Tomer A, Manatunga AK, Knight BT, Porter MR, Kasey S, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996;153:1313-7.
14. Musselman DL, Marzec UM, Manatunga A, Penna S, Reemsnyder A, Knight BT, et al. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry 2000;57:875-82.
15. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H. Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatr Scand 1996;94:198-204.
16. Taniguchi S, Hamada T. Photosensitivity and thrombocytopenia due to amitriptyline. Am J Hematol 1996;53:49-50.
17. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991;84:613-7.
18. Van Kempen GMJ, Zitman FG, Linssen ACG, Edelbrock PM. Biochemical measures in patients with a somatoform pain disorder, before, during and after treatment with amitriptyline with or without flupentixol. Pain 1991;47:25-30.